Victory Capital Management
PGEN icon

Victory Capital Management’s Precigen PGEN Stock Holding History

Victory Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$964K Sell
169,171
-33,511
-17% -$145K ﹤0.01% 1910
2026
Q1 		$784K Sell
202,682
-33,950
-14% -$139K ﹤0.01% 1928
2025
Q4 		$989K Buy
236,632
+219,627
+1,292% +$850K ﹤0.01% 1842
2025
Q3 		$55.9K Sell
17,005
-2,304
-12% -$6.5K ﹤0.01% 2332
2025
Q2 		$27.4K Sell
19,309
-309
-2% -$439 ﹤0.01% 2422
2025
Q1 		$29.2K Buy
19,618
+1,360
+7% +$2.14K ﹤0.01% 2406
2024
Q4 		$20.4K Sell
18,258
-688
-4% -$587 ﹤0.01% 2440
2024
Q3 		$17.9K Buy
18,946
+2,046
+12% +$2.58K ﹤0.01% 2449
2024
Q2 		$26.7K Buy
16,900
+435
+3% +$632 ﹤0.01% 2409
2024
Q1 		$23.9K Sell
16,465
-390
-2% -$560 ﹤0.01% 2434
2023
Q4 		$22.6K Buy
16,855
+3,659
+28% +$4.3K ﹤0.01% 2503
2023
Q3 		$18.7K Sell
13,196
-820
-6% -$1.16K ﹤0.01% 2450
2023
Q2 		$16.1K Sell
14,016
-326
-2% -$385 ﹤0.01% 2460
2023
Q1 		$15.2K Buy
14,342
+3,003
+26% +$4.33K ﹤0.01% 2527
2022
Q4 		$17.2K Sell
11,339
-5
-0% -$9 ﹤0.01% 2518
2022
Q3 		$24K Sell
11,344
-3,245
-22% -$6.84K ﹤0.01% 2613
2022
Q2 		$20K Sell
14,589
-31
-0.2% -$46 ﹤0.01% 2617
2022
Q1 		$19K Sell
14,620
-418
-3% -$1.02K ﹤0.01% 2644
2021
Q4 		$56K Sell
15,038
-460
-3% -$1.98K ﹤0.01% 2634
2021
Q3 		$77K Sell
15,498
-114
-0.7% -$656 ﹤0.01% 2652
2021
Q2 		$102K Buy
15,612
+153
+1% +$1.07K ﹤0.01% 2598
2021
Q1 		$107K Buy
15,459
+3,653
+31% +$30.9K ﹤0.01% 2596
2020
Q4 		$120K Buy
11,806
+1,671
+16% +$10.8K ﹤0.01% 2405
2020
Q3 		$35K Sell
10,135
-504
-5% -$2.39K ﹤0.01% 2400
2020
Q2 		$53K Buy
10,639
+2,116
+25% +$7.2K ﹤0.01% 2396
2020
Q1 		$29K Sell
8,523
-8,437
-50% -$36.4K ﹤0.01% 2691
2019
Q4 		$93K Buy
16,960
+5,092
+43% +$28.7K ﹤0.01% 2558
2019
Q3 		$68K Buy
+11,868
New +$80.6K ﹤0.01% 2565

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Victory Capital Management's PGEN Position: Q2 2026 in Review

Victory Capital Management reduced its Precigen (PGEN) stake by 17% in Q2 2026, selling an estimated $145K and leaving 169,171 shares worth $964K. The position accounts for ﹤0.01% of the portfolio, ranked #1910.

Victory Capital Management first reported a position in PGEN in Q3 2019 and has held it in 28 quarters since. The position peaked at $989K in Q4 2025. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Victory Capital Management held 169,171 shares of Precigen worth $964K as of Q2 2026.
  • Victory Capital Management sold 33,511 Precigen shares in Q2 2026, an estimated $145K.
  • Precigen made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1910 holding.
  • Victory Capital Management first reported a position in Precigen in Q3 2019 and has held it in 28 quarters since.
  • Victory Capital Management's Precigen position peaked at $989K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.